Melanoma Workshop

Organizing committee:

Corine Bertolotto: C3M, INSERM U1065, Nice, France
Robert Ballotti: C3M, INSERM U1065, Nice, France

1. Non-sun related Melanoma
2. New pathways/melanoma genes
3. Emerging technologies for probing magnitude/dynamics of intra-tumor heterogeneity
4. Tumor initiation, cell(s)-of-origin or animal model
5. Non-genetic Intratumor Heterogeneity
6. Progression & Metastasis (Metabolism, Micro-environment)
7. Immunotherapy
8. Therapy resistance

• Andrew APLIN, Thomas Jefferson University, Philadelphia, USA
• Emily BERNSTEIN, Mount Sinai, New York, USA
• Corine BERTOLOTTO, C3M, INSERM U1065, Nice, France
• Geneviève BOLAND, Massachusetts General Hospital, Boston, USA
• Julie CARAMEL, Cancer Research Center of Lyon, Lyon, France
• Pierre CLOSE, University of Liege, Liege, Belgium
• Irwin DAVIDSON, Institute of Genetics and Molecular and Cellular Biology, Strasbourg, France
• Keith FLAHERTY, Massachusetts General Hospital, Boston, USA
• Arnaud DE LA FOUCHARDIERE, Leon Berard Centre, Lyon, France
• Marie-Dominique GALIBERT, Institute of Genetics and Development, Rennes, France
• Colin GODING, Ludwig Institute for Cancer Research, Oxford, UK
• Miguel GODINHO FERREIRA, Institute for Research on Cancer and Aging, Nice, France
• Michael HOLZEL, University of Bonn, Bonn, Germany
• Stéphanie KREIS, University of Luxembourg, Luxembourg
• Luisa LANFRANCONE, European Institute of Oncology, Milan, Italy
• Lionel LARUE, Curie Institute, Paris, France
• Eleonora LEUCCI, VIB, KU Leuven, Leuven, Belgium
• Mitchell LEVESQUE, University of Zurich, Zurich, Switzerland
• Carmit LEVY, Weizmann Institute of Science, Rehovot, Israel
• Laurence NIETO, University Paul Sabatier, Toulouse, France
• Jean-Christophe MARINE, VIB, KU Leuven, Leuven, Belgium
• Thierry PASSERON, Nice Hospital, Nice, France
• Elizabeth PATTON, University of Edinburgh, Edinburgh, UK
• Daniel PEEPER, Netherlands Cancer Institute, Amsterdam, The Netherlands
• Florian RAMBOW, VIB, KU Leuven, Leuven, Belgium
• Daniela ROBLES-ESPINOZA, International Laboratory for Human Genome Research, Querétaro, Mexico
• Ze’ev RONAI, Sanford Burnham Prebys Institute, San Diego, USA
• Yardena SAMUELS, Weizmann Institute of Science, Rehovot, Israel
• Daniel SCHULZ, University of Zurich, Zurich, Switzerland
• Marisol SOENGAS, National Cancer Research Center, Madrid, Spain
• Eirikur STEINGRIMSSON, University of Iceland, Reykjavik, Iceland
• Stéphan VAGNER, Curie Institute, Paris, France
• Richard WHITE, Memorial Sloan Kettering Cancer Center, New York, USA
• Marie-Laure YASPO, Max Planck Institute for Molecular Genetics, Berlin, Germany